PUBLICATIONS

Publications from the PanCareSurPass project

PanCareSurPass is an EU-funded project looking at how to more widely implement the digital Survivorship Passport (SurPass) to improve survivorship care for survivors of childhood and adolescent cancer in Europe. PanCareSurPass developed, tested and implemented the SurPass in participating countries and will develop material to support implementation in other countries

Title Authors Link PLAIN language summary PDF
Childhood Cancer Survivorship Passport Challenges in the European Health Data Space Gazzarata R et al. Studies in Health Technology and Informatics 2024.
https://doi.org/10.3233/SHTI240651
PDF
IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital Survey de Beijer IAE et al. JMIR 2024.
https://doi.org/10.2196/49910
PDF
Scaling up and implementing the digital Survivorship Passport tool in routine clinical care – The European multidisciplinary PanCareSurPass project Filbert AL et al. Eur. J. Cancer 2024.
https://doi.org/10.1016/j.ejca.2024.114029
European recommendations for short-term surveillance of health problems in childhood, adolescent and young adult cancer survivors from the end of treatment to 5 years after diagnosis: a PanCare guideline de Beijer IAE et al. J. Cancer Survivorship 2023.
https://doi.org/10.1007/s11764-023-01493-z
PDF
Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study de Beijer IAE et al. J. Cancer Survivorship 2023.
https://doi.org/10.1007/s11764-023-01498-8
PLAIN summary PDF
Barriers and facilitators to implementation of the interoperable Survivorship Passport (SurPass) v2.0 in 6 European countries: a PanCareSurPass online survey study van den Oever S et al. J. Cancer Survivorship 2023;164.
https://doi.org/10.1007/s11764-023-01335-y
PLAIN summary PDF
Factors Influencing Implementation of the Survivorship Passport: The IT Perspective Chronaki C et al. Stud Health Technol Inform. 2022 May 16;293:161-168.
https://doi.org/10.3233/SHTI220363
PDF

 

Publications from the PanCareFollowUp project

PanCareFollowUp was an EU-funded project looking at how to best deliver survivorship care to survivors of childhood and adolescent cancer in Europe. The aim of PanCareFollowUp was to deliver care according to recently developed guidelines using an innovative model for person centred care that empowers survivors and supports self-management.

Title Authors Link PLAIN language summary PDF
Barriers and facilitators associated with long term follow-up care for childhood, adolescent, and young adult cancer survivors: a systematic review de Beijer IAE et al.

BMC Health Services Research (2025) 25:1331
https://doi.org/10.1186/s12913-025-13363-8

  PDF
Efficacy of the PanCareFollowUp eHealth Lifestyle Intervention for Survivors of Childhood, Adolescent and Young Adult Cancer van den Oever et al. Cancer Medicine 2025, 14:e70694. https://doi.org/10.1002/cam4.70694 PLAIN summary PDF
Barriers, facilitators, and other factors associated with health behaviors in childhood, adolescent, and young adult cancer survivors: A systematic review de Beijer et al. Cancer Medicine 2024, 13(12):e7361. https://doi.org/10.1002/cam4.7361 PLAIN summary PDF
From long-term follow-up Recommendations for clinical practice to plain language summaries for childhood, adolescent, and young adult cancer survivors van den Oever et al. EJC Paediatric Oncology 2024 3 100165
https://doi.org/10.1016/j.ejcped.2024.100165
PLAIN summary PDF
Healthcare providers’ expected barriers and facilitators to the implementation of person‐centered long‐term follow‐up care for childhood cancer survivors: A PanCareFollowUp study Breij et al. Cancer Medicine 2024, 13(20), e70225. https://doi.org/10.1002/cam4.70225 PLAIN summary PDF
Perceived barriers and facilitators to health behaviors in European childhood cancer survivors Bouwman E et al.

Cancer Medicine 2023, 12(11): 12035-12959

https://doi.org/10.1002/cam4.5911

PLAIN summary PDF
Healthcare professionals’ perceived barriers and facilitators of health behavior support provision: A qualitative study Bouwman E et al.

Cancer Medicine. 2023;12:7414–7426.

https://doi.org/10.1002/cam4.5445

PLAIN summary PDF
Person-centred online lifestyle coaching in childhood, adolescent, and young adult cancer survivors: protocol of the multicentre PanCareFollowUp lifestyle intervention feasibility study Bouwman E et al.

Pilot and Feasibility Studies (2022) 8:260

https://doi.org/10.1186/s40814-022-01221-x

PLAIN summary PDF
Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol van Kalsbeek RJ et al.

BMJ Open 2022;12:e063134.

https://doi.org/10.1136/bmjopen-2022-063134

PLAIN summary PDF
The PanCareFollowUp Care Intervention: A European harmonised approach to person-centred guideline-based survivorship care after childhood, adolescent and young adult cancer van Kalsbeek RJ et al.

European Journal of Cancer 162; Feb 2022; 34 – 44

https://doi.org/10.1016/j.ejca.2021.10.035

PLAIN summary PDF
European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer van Kalsbeek RJ et al.

European Journal of Cancer 154; Sep 2021; 316 – 328

https://doi.org/10.1016/j.ejca.2021.06.004

PLAIN summary PDF
The European multistakeholder PanCareFollowUp project: novel, person-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for cancer survivors and caregivers van Kalsbeek RJ et al.

European Journal of Cancer 153; Aug 2021; 74 – 85

https://doi.org/10.1016/j.ejca.2021.05.030

PLAIN summary PDF

Publications from the PanCareLIFE project

PanCareLIFE was a 5-year (2013-8) EU Framework 7 Programme in the Health Theme that studied the impact of treatment regimes on the long-term health of childhood cancer survivors. Specifically, PanCareLIFE evaluated the risks of impairments in female fertility, in hearing, and in quality of life. PanCareLIFE also developed two guidelines for fertility preservation, and will disseminate widely the results from this project. Below an overview of publications that were made within the PanCareLIFE project.

Title Authors Link PDF
Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study Strebel S et al. J Cancer Surviv. 2025 Feb;19(1):162-173
https://doi.org/10.1007/s11764-023-01456-4
PDF
Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors – a genome-wide association study: results from PanCareLIFE Van der Perk MEM et al. Fertil Steril. 2024 Sep;122(3):514-524.
https://doi.org/10.1016/j.fertnstert.2024.05.002
PDF
The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium Scobioala S et al. Int J Cancer. 2024 Jan 15;154(2):320-331
https://doi.org/10.1002/ijc.34732
PDF
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study Van der Perk MEM et al. Cancers (Basel). 2021 Sep 13;13(18):4598.
https://doi.org/10.3390/cancers13184598
PDF
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. Meijer AJM et al. NPJ Precision Oncology; 5:64: February 2021.
https://doi.org/10.1038/s41698-021-00178-z
PDF
Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE). van den Berg H et al. Human Reproduction 0:1–13. 2021.
https://doi.org/10.1093/humrep/deab035
PDF
Managing a pan-European consortium on late effects among long-term survivors of childhood and adolescent cancer – the PanCareLIFE project. Kaatsch P et al. Int J Environ Res Public Health 2021, 18, 3918.
https://doi.org/10.3390/ijerph18083918.
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function, van der Kooi ALF et al. Human Reproduction deaa342, 2021.
https://doi.org/10.1093/humrep/deaa342.
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Mulder RL et al. The Lancet Oncology 22, e45 – e56, 2021.
https://doi.org/10.1016/S1470-2045(20)30594-5
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Mulder RL et al. The Lancet Oncology 22, e57 – e67, 2021.
https://doi.org/10.1016/S1470-2045(20)30582-9
Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Mulder RL et al. The Lancet Oncology 22, e68 – e80, 2021.
https://doi.org/10.1016/S1470-2045(20)30595-7
Health-related quality of life in European childhood cancer survivors: protocol for a study within PanCareLIFE . Calaminus G et al. JMIR Res Protoc 2021, 10: e21851
https://doi.org/10.2196/21851
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study. Langer T et al. Eur J Cancer. 138, 212-224, 2020.
https://doi.org/10.1016/j.ejca.2020.07.019
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Langer T et al. Data in Brief 32:106227, 2020.
https://doi.org/10.1016/j.dib.2020.106227
PDF
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study. Clemens E et al. Pharmacogenomics J 20, 294–305, 2020.
https://doi.org/10.1038/s41397-019-0113-1
Determinants of utilization of cryopreservation of germ cells in adolescent cancer patients in four European countries. Balcerek M et al. Eur J Pediatr. 2020 Jan;179(1):51-60.
https://doi.org/10.1007/s00431-019-03459-9
Fertility education for adolescent cancer patients: Gaps in current clinical practice in Europe. Korte E et al. Eur J Cancer Care 2020 Sep. Sep;29(5):e13279.
https://doi.org/10.1111/ecc.13279
PDF
Fertility-Related Wishes and Concerns of Adolescent Cancer Patients and Their Parents. Korte E et al. J Adolesc Young Adult Oncol. 2020 Feb;9(1):55-62.
https://doi.org/10.1089/jayao.2019.0064
Fertility knowledge and associated empowerment following an educational intervention for adolescent cancer patients. Borgmann-Staudt A et al. Psychooncology. 2019 Nov;28(11):2218-2225.
https://doi.org/10.1002/pon.5210
Hearing loss and quality of life in survivors of paediatric CNS tumours and other cancers Weiss A et al. Qual Life Res 28, 515–521 (2019).
https://doi.org/10.1007/s11136-018-2021-2
Genetic determinants of ototoxicity during and after childhood cancer treatment: protocol for the PanCareLIFE study. Clemens E et al. JMIR Res Protoc 8, e11868, 2019.
https://doi.org/10.2196%2F11868
PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity, and health related quality of life after cancer occurring among children and adolescents. Byrne J et al. Eur J Cancer 103, 227-237, 2018.
https://doi.org/10.1016/j.ejca.2018.08.007
PDF
Genetic variation in gonadal impairment in female survivors of childhood cancer: design of a PanCareLIFE study. van der Kooi ALF et al. BMC Cancer 18, 930.
https://doi.org/10.1186/s12885-018-4834-3
PDF
Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE). van den Berg M et al. JMIR Res Protoc 7, e10824, 2018.
https://doi.org/10.2196%2F10824
Europäische PanCare-Studien zu Spätfolgen nach Krebs im Kindes- und Jugendalter Grabow D et al. Onkologe 24, 754–759 (2018).
https://doi.org/10.1007/s00761-018-0449-1
The influence of genetic variation on late toxicities in childhood cancer survivors Clemens E et al. Critical Reviews in Oncology / Hematology 126 (2018) 154–167
https://doi.org/10.1016/j.critrevonc.2018.04.001
PDF
Audiological monitoring in Swiss childhood cancer patients Weiss A et al. Pediatric Blood & Cancer, 10.1002/pbc.26877, 65, 3, (2017).
https://doi.org/10.1002/pbc.26877
Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors Clemens E et al. Pediatric Hematology and Oncology, 34(2), 120–129.
https://doi.org/10.1080/08880018.2017.1323985
PDF
Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study Weiss A et al. PLoS ONE 12 (3): e0174479.
https://doi.org/10.1371/journal. pone.0174479
PDF
Socio-demographic impact of platinum-induced ototoxicity in long-term survivors of childhood cancer Clemens E et al. Curr Pediatr Res 2017; 21 (3): 470-479
https://www.researchgate.net/publication/325170052_Socio-demographic_impact_of_platinum-induced_ototoxicity_in_long-term_survivors_of_childhood_cancer
PDF
Longitudinal follow-up in female Childhood Cancer Survivors: no signs of accelerated ovarian function loss Van der Kooi ALF et al. Hum Reprod 2017 32:193-200
https://doi.org/10.1093/humrep/dew278
PDF
Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study Clemens et al. Eur J Cancer 2016 69:77-85
https://doi.org/10.1016/j.ejca.2016.09.023
Fertility preservation in children, adolescents and young adults with cancer: Quality of clinical practice guidelines and variations in recommendations Font-Gonzalez A et al. Cancer 2016: Cancer 2016 122(14):2216-23
https://doi.org/10.1002/cncr.30047
PDF

Publications from the PanCareSurFup project

PanCareSurFup (PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies) was a consortium of 16 European institutions in 11 countries, funded by the 7th Framework Programme of the EC, and carried out research studies into late effects of treatment for cancer, established guidelines for follow-up, and disseminated the results and provided training and workshops for stakeholders..

Title Authors Link PDF
Risk Factors for Valvulopathy Among Childhood Cancer Survivors Aho Glele R et al.

AMA Oncol. 2025 Oct 9:e253863
https://doi.org/10.1001/jamaoncol.2025.3863

 
Radiation Doses Received by Major Organs at Risk in Children and Young Adolescents Treated for Cancer with External Beam Radiation Therapy: A Large-scale Study from 12 European Countries Diallo I et al. Int J Radiat Oncol Biol Phys. 2024 Oct 1;120(2):439-453.
https://doi.org/10.1016/j.ijrobp.2024.03.032
 
Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study Heymer EJ et al. Br J Cancer. 2024 Apr;130(6):976-986
https://doi.org/10.1038/s41416-024-02577-y
PDF
Cumulative Absolute Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors: A PanCareSurFup Study Heymer EJ et al. J Clin Oncol. 2024 Jan 20;42(3):336-347
https://doi.org/10.1200/JCO.23.00452
PDF
Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study Reulen RC et al. J Clin Oncol. 2023 Jul 20;41(21):3735-3746
https://doi.org/10.1200/JCO.22.02045
PDF
Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study Dudley IM et al. Cancer. 2023 Feb 1;129(3):426-440
https://doi.org/10.1002/cncr.34561
PDF
Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study de Baat EC et al. J Clin Oncol. 2023 Jan 1;41(1):96-106
https://doi.org/10.1200/JCO.21.02944
PDF
Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort Trama A et al. Pediatr Blood Cancer. 2022 Dec;69(12):e29991
https://doi.org/10.1002/pbc.29991
PDF
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study Sunguc C et al. Br J Cancer. 2023 Jan;128(1):80-90
https://doi.org/10.1038/s41416-022-02016-w
PDF
Recommendations for the surveillance of education and employment outcomes in survivors of childhood, adolescent, and young adult cancer: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group Devine KA et al. Cancer. 2022 Jul 1;128(13):2405-2419
https://doi.org/10.1002/cncr.34215
PDF
Male breast cancer after childhood cancer: Systematic review and analyses in the PanCareSurFup cohort. Wang Y et al. Eur J Cancer. 2022 Apr;165:27-47.
https://doi.org/10.1016/j.ejca.2022.01.001
 
Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium. Byrne J et al. Int J Cancer. 2022 Feb 1;150(3):406-419.
https://doi.org/10.1002/ijc.33817
PDF
REPORT: Handbook for guideline development; collaboration between International Guideline Harmonization Group, PanCareSurFup and Cochrane Childhood Cancer Group. Mulder RL et al.   PDF
Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group Bardi E et al. Cancer Treat Rev. 2021 Nov:100:102296
https://doi.org/10.1016/j.ctrv.2021.102296
 
Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study. Feijen EAM et al. Heart. 2021 Jan;107(1):33-40.
https://doi.org/10.1136/heartjnl-2020-316655
PDF
Recommendations for the surveillance of cancer-related fatigue in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group Christen S et al. J Cancer Surviv. 2020 Dec;14(6):923-938
10.1007/s11764-020-00904-9
PDF
Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study. Reulen RC et al. Gut. 2020 Nov 2:gutjnl-2020-322237.
https://doi.org/10.1136/gutjnl-2020-322237
PDF
Late mortality in survivors of childhood cancer in Hungary Jakab Z et al. Sci Rep. 2020 Jul 1;10(1):10761
https://doi.org/10.1038/s41598-020-67444-1
PDF
Towards a European health research and innovation cloud (HRIC) Aarestrup FM et al. Genome Med. 2020 Feb 19;12(1):18
https://doi.org/10.1186/s13073-020-0713-z
PDF
Evidence-based recommendations for the organization of long-term follow-up care for childhood and adolescent cancer survivors: a report from the PanCareSurFup Guidelines Working Group. Michel G et al. J Cancer Surviv. 2019 Oct;13(5):759-772.
https://doi.org/10.1007/s11764-019-00795-5
 
Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort Teepen JC et al. Cancer Causes Control. 2019 Sep;30(9):909-922
https://doi.org/10.1007/s10552-019-01204-z
PDF
Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup. Allodji RS et al. Eur J Cancer. 2019 Aug;117:71-83
https://doi.org/10.1016/j.ejca.2019.05.013
 
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry Bagnasco F et al. Eur J Cancer. 2019 Mar:110:86-97
https://doi.org/10.1016/j.ejca.2018.12.021
 
Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium Clemens E et al. Lancet Oncol. 2019 Jan;20(1):e29-e41
https://doi.org/10.1016/S1470-2045(18)30858-1
PDF
The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer. Byrne J et al. Eur J Cancer. 2018 Nov;103:238-248.
https://doi.org/10.1016/j.ejca.2018.08.017
 
The ‘Survivorship Passport’ for childhood cancer survivors. Haupt R et al. Eur J Cancer. 2018 Oct;102:69-81.
https://doi.org/10.1016/j.ejca.2018.07.006
PDF
Respiratory mortality of childhood, adolescent and young adult cancer survivors Fidler MM et al. Thorax. 2018 Oct;73(10):959-968.
https://doi.org/10.1136/thoraxjnl-2017-210683
PDF
Risk of subsequent colorectal cancers after a solid tumor in childhood: Effects of radiation therapy and chemotherapy Allodji RS et al. Pediatr Blood Cancer.2018. 66(2): p. e27495.
https://doi.org/10.1002/pbc.27495
 
Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe. Bright CJ et al. J Natl Cancer Inst. 2018 Jun 1;110(6):649-660.
https://doi.org/10.1093/jnci/djx235
PDF
The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries. Grabow D et al. Eur J Epidemiol. 2018 Mar;33(3):335-349.
https://doi.org/10.1007/s10654-018-0370-3
PDF
Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe. Fidler MM et al. J Natl Cancer Inst. 2018 Feb 1;110(2).
https://doi.org/10.1093/jnci/djx165
PDF
Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium Clement SS et al. Cancer Treat Rev. 2018 Feb:63:28-39.
https://doi.org/10.1016/j.ctrv.2017.11.005
 
Pregnancy and Labor Complications in Female Survivors of Childhood Cancer: The British Childhood Cancer Survivor Study Reulen RC et al. J Natl Cancer Inst. 2017 Nov 1;109(11):djx056.
https://doi.org/10.1093/jnci/djx056
PDF
Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Skinner R et al. Lancet Oncol. 2017 Feb;18(2):e75-e90.
https://doi.org/10.1016/S1470-2045(17)30026-8
 
A review of uncertainties in radiotherapy dose reconstruction and their impacts on dose-response relationships Bezin JV et al. J Radiol Prot. 2017 Mar 20;37(1):R1-R18
https://doi.org/10.1088/1361-6498/aa575d
PDF
Adverse health outcomes among long-term survivors of childhood, teenage and young adult cancer Bright CJ Thesis 2017 PDF
Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium. van Dorp W et al. J Clin Oncol. 2016 Oct 1;34(28):3440-50.
https://doi.org/10.1200/JCO.2015.64.3288
PDF
Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFup. Feijen EA et al. PLoS One. 2016 Sep 19;11(9):e0162778.
https://doi.org/10.1371/journal.pone.0162778
PDF
Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study Fidler MM et al. BMJ. 2016 Sep 1:354:i4351.
https://doi.org/bmj.i4351
PDF
Transition guidelines: An important step in the future care for childhood cancer survivors. A comprehensive definition as groundwork. Mulder RL et al. Eur J Cancer, 2016 Feb, 54: 64-68
https://doi.org/10.1016/j.ejca.2015.10.007
 
The European Experience of Establishing Guidelines for Surveillance of the Childhood Cancer Survivor, in Handbook of Long Term Care of the Childhood Cancer Survivor. Skinner R et al.
In Handbook of Long-Term Care of the Childhood Cancer Survivor; Mucci, G., Torno, L., Eds.;
Springer: New York, NY, USA, 2015; pp. 25–35

https://doi.org/10.1007/978-1-4899-7584-3_3

 
Surveillance of late effects by treatment: the European experience. Skinner R et al.
In Handbook of Long-Term Care of the Childhood Cancer Survivor; Mucci, G., Torno, L., Eds.;
Springer: New York, NY, USA, 2015; pp. 25–35

https://doi.org/10.1007/978-1-4899-7584-3_3

 
Cardiac Diseases Following Childhood Cancer Treatment: Cohort Study. Haddy N et al. Circulation. 2016 Jan 5;133(1):31-8.
https://doi.org/10.1161/CIRCULATIONAHA.115.01668610.1016/j.ejca.2015.04.002
PDF
Risks of adverse health and social outcomes among childhood cancer survivors Guha J Thesis 2015 PDF
Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care. Hjorth L et al. Eur J Cancer, 2015. 51(10): 1203-1211.
https://doi.org/10.1016/j.ejca.2015.04.002
PDF
Childhood cancer survivor cohorts in Europe Winther JF et al. Acta Oncol. 2015 May;54(5):655-68
https://doi.org/10.3109/0284186X.2015.1008648
PDF
The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors. Brown MC et al. Pediatr Blood Cancer. 2015 Feb;62(2):322-328.
https://doi.org/10.1002/pbc.25310
PDF
Recommendations for Cardiomyopathy Surveillance for Survivors of Childhood Cancer: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Armenian SH et al. Lancet Oncology 2015; 16: e123-136.
https://doi.org/10.1016/s1470-2045(14)70409-7
PDF
A New Method to Facilitate Valid and Consistent Grading Cardiac Events in Childhood Cancer Survivors Using Medical Records Feijen EL et al. PLoS One. 2014; 9(7): e100432.
https://doi.org/10.1371/journal.pone.0100432
PDF
Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment. Schwartz B et al. Radiat Environ Biophys, 2014. 53(2): 381-90.
https://doi.org/10.1007/s00411-013-0510-9
PDF
Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group Mulder RL et al. Lancet Oncol, 2013. 14(13): e621-9.
https://doi.org/10.1016/S1470-2045(13)70303-6
PDF
Health problems in survivors of childhood cancer: the need for international collaboration in long-term follow-up care Mulder RL et al. Future Oncol. 2013 Nov;9(11):1667-70
https://doi.org/10.2217/fon.13.107
PDF
Transitional care of a childhood cancer survivor to adult services, facilitating the process of individual access to different models Frey E et al. Curr Opin Support Palliat Care. 2013 Sep;7(3):309-13.
https://doi.org/10.1097/SPC.0b013e32836484bb
 
Developing international consensus for late effects screening and guidance. Skinner R et al. Current Opinion in Supportive and Palliative Care 7(3):p 303-308, September 2013.
https://doi.org/10.1097/SPC.0b013e328363a607
 
Transitional care of a childhood cancer survivor to adult services: facilitating the process of individual access to different models Frey E et al. Current Opinion in Supportive and Palliative Care 7(3):p 309-313, September 2013.
https://doi.org/10.1097/SPC.0b013e32836484bb
 
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Kremer LC et al. Pediatr Blood Cancer, 2013. 60(4): 543-9.
https://doi.org/10.1002/pbc.24445
PDF
Cohort profile: The Swiss Childhood Cancer Survivor Study. Kuehni CE et al. Int J Epidemiol,2012. 41(6): 1553-1564.
https://doi.org/10.1093/ije/dyr142
PDF
Total heart volume as a function of clinical and anthropometric parameters in a population of external beam radiation therapy patients Badouna AN et al. Phys Med Biol. 2012 Jan 21;57(2):473-84
https://doi.org/10.1088/0031-9155/57/2/473